Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.74 - $1.64 $4,997 - $11,074
-6,753 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.24 - $3.03 $1,919 - $4,690
-1,548 Reduced 18.65%
6,753 $10,000
Q4 2021

Feb 15, 2022

BUY
$2.58 - $6.13 $2,319 - $5,510
899 Added 12.15%
8,301 $23,000
Q3 2021

Nov 15, 2021

SELL
$4.42 - $10.61 $12,331 - $29,601
-2,790 Reduced 27.37%
7,402 $42,000
Q2 2021

Aug 16, 2021

SELL
$9.15 - $20.17 $13,294 - $29,307
-1,453 Reduced 12.48%
10,192 $109,000
Q1 2021

May 18, 2021

BUY
$18.76 - $40.91 $218,460 - $476,396
11,645 New
11,645 $260,000

About Sigilon Therapeutics, Inc.


  • Ticker SGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,399,300
  • Description
  • Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...
More about SGTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.